Oral antiviral treatments for COVID-19: opportunities and challenges

L Rahmah, SO Abarikwu, AG Arero, M Essouma… - Pharmacological …, 2022 - Springer
… that COVID-19 can … COVID-19, (iv) discusses ethical issues in such clinical trials and (v)
presents challenges associated with the use of oral antivirals in clinical practice. Oral COVID-19

[HTML][HTML] Minimum costs to manufacture new treatments for COVID-19

A Hill, J Wang, J Levi, K Heath, J Fortunak - Journal of Virus Eradication, 2020 - Elsevier
… was to apply the same calculations to the new candidate treatments for COVID-19. … for
treatment for some indications in all countries, but few are approved for treatment of COVID-19. …

COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs

A Tufan, AA Güler… - Turkish journal of medical …, 2020 - journals.tubitak.gov.tr
… immune-suppressive treatments such as hydroxychloroquine… be considered as treatment
choices for COVID-19, particularly … treatments, mostly used in rheumatology for COVID-19, we …

COVID19 diagnosis and management: a comprehensive review

G Pascarella, A Strumia, C Piliego… - Journal of internal …, 2020 - Wiley Online Library
… Here, we provide an overview of the known clinical features and treatment options for
COVID-19. We carried out a systematic literature search using the main online databases (PubMed…

Molnupiravir: A new candidate for COVID19 treatment

F Pourkarim, S Pourtaghi‐Anvarian… - Pharmacology …, 2022 - Wiley Online Library
COVID-19. Molnupiravir is an antiviral drug with anti-RNA polymerase activity and currently
is under investigation for the treatment of patients with COVID-19. … the treatment of COVID-19

COVID19: immunopathology, pathophysiological mechanisms, and treatment options

LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
… of patients with COVID-19 provide valuable information with … treatment regimens. This
review provides an updated overview of the main pathological changes observed in COVID-19

[HTML][HTML] The place for remdesivir in COVID-19 treatment

B Young, TT Tan, YS Leo - The Lancet. Infectious Diseases, 2021 - ncbi.nlm.nih.gov
COVID-19.1, 2 Interim results from the WHO-led, open-label, randomised SOLIDARITY trial
3 of patients with COVID-19 … For now, remdesivir is an important COVID-19 treatment option …

The rheumatologist's role in COVID-19

RQ Cron, WW Chatham - The Journal of rheumatology, 2020 - jrheum.org
… , we propose that every hospitalized patient with COVID-19 is deserving of a serum ferritin …
institution of treatment for CSS, the better the outcomes 11 . The ideal treatment for COVID-19–…

The impact of the COVID-19 pandemic on cancer patients

OM Al-Quteimat, AM Amer - American journal of clinical oncology, 2020 - journals.lww.com
… no specific treatment or approved vaccine against COVID-19 … 33% of patients with COVID-19
and include acute respiratory … no specific treatment or approved vaccine against COVID-19, …

Remdesivir in covid-19

RE Ferner, JK Aronson - Bmj, 2020 - bmj.com
… The mechanism of action of remdesivir makes it potentially useful in the treatment of covid-19. …
of several treatments at once and permit interim analyses after which treatments may be …